Castella, B., Melaccio, A., Foglietta, M., Riganti, C., & Massaia, M. (2018). Vγ9Vδ2 T Cells as Strategic Weapons to Improve the Potency of Immune Checkpoint Blockade and Immune Interventions in Human Myeloma. Front Oncol.
Citação norma ChicagoCastella, Barbara, Assunta Melaccio, Myriam Foglietta, Chiara Riganti, and Massimo Massaia. "Vγ9Vδ2 T Cells As Strategic Weapons to Improve the Potency of Immune Checkpoint Blockade and Immune Interventions in Human Myeloma." Front Oncol 2018.
Citação norma MLACastella, Barbara, et al. "Vγ9Vδ2 T Cells As Strategic Weapons to Improve the Potency of Immune Checkpoint Blockade and Immune Interventions in Human Myeloma." Front Oncol 2018.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.